mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.08 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.08 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.08 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
-0.06 |
0.08 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.08 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.08 |